Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2016 Feb 26;60(3):1953. doi: 10.1128/AAC.00179-16

Erratum for Kamal et al., A Drug-Disease Model Describing the Effect of Oseltamivir Neuraminidase Inhibition on Influenza Virus Progression

Mohamed A Kamal a, Ronald Gieschke b, Annabelle Lemenuel-Diot b, Catherine A A Beauchemin c, Patrick F Smith d,e, Craig R Rayner d,f
PMCID: PMC4775932  PMID: 26921415

ERRATUM

Volume 59, no. 9, p. 5388–5395, 2015. Page 5391, Table 2: It was brought to our attention that there was an inadvertent error in reporting the residual error term (σerror, Table 2) in our model. The minor error is isolated and has no impact on the stated objectives of the paper, the integrity or interpretation of the results, and the final conclusions. Because the pharmacodynamic effect is measured and modeled as log10 of TCID50/ml (viral load), it should in fact be reported and defined as an additive error term in log and not a proportional term as a CV% (coefficient of variation percentage). The additive error term is reported as the standard deviation or square root of the variance provided by NONMEM and, as such, based on the NONMEM output provided in the supplemental material, we report the correct residual error (σerror, Table 2) as 1.07 (square root of 1.15) in log TCID50/ml.


Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES